Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
[The prevalently arterial vasodilators].

Giornale italiano di cardiologia

Camerini F, Klugmann S, Borgioni L, Salvi A.
PMID: 548301
G Ital Cardiol. 1979;9:20-2.

No abstract available.

Cite
Camerini F, Klugmann S, Borgioni L, et al. I vasodilatatori prevalentemente arteriosi. [The prevalently arterial vasodilators]. G Ital Cardiol. 1979;9:20-2
Camerini, F., Klugmann, S., Borgioni, L., & Salvi, A. (1979). I vasodilatatori prevalentemente arteriosi. [The prevalently arterial vasodilators]. Giornale italiano di cardiologia, 920-2.
Camerini, F, et al. "I vasodilatatori prevalentemente arteriosi." [The prevalently arterial vasodilators]. Giornale italiano di cardiologia vol. 9 (1979): 20-2.
Camerini F, Klugmann S, Borgioni L, Salvi A. I vasodilatatori prevalentemente arteriosi. [The prevalently arterial vasodilators]. G Ital Cardiol. 1979;9:20-2. Italian. PMID: 548301.
Copy Download .nbib Format: NLM
Vasodilators in acute myocardial infarction.

Indian heart journal

Khalilullah M, Gambhir DS.
PMID: 3836933
Indian Heart J. 1985 Nov-Dec;37(6):336-8.

No abstract available.

Cite
Khalilullah M, Gambhir DS. Vasodilators in acute myocardial infarction. Indian Heart J. 1985;37(6):336-8
Khalilullah, M., & Gambhir, D. S. (1985). Vasodilators in acute myocardial infarction. Indian heart journal, 37(6), 336-8.
Khalilullah, M, and Gambhir, D S. "Vasodilators in acute myocardial infarction." Indian heart journal vol. 37,6 (1985): 336-8.
Khalilullah M, Gambhir DS. Vasodilators in acute myocardial infarction. Indian Heart J. 1985 Nov-Dec;37(6):336-8. PMID: 3836933.
Copy Download .nbib Format: NLM
Vasodilators in Septic Shock Resuscitation: A Clinical Perspective.

Shock (Augusta, Ga.)

Corrêa TD, Filho RR, Assunção MS, Silva E, Lima A.
PMID: 27787407
Shock. 2017 Mar;47(3):269-275. doi: 10.1097/SHK.0000000000000777.

Microcirculatory abnormalities have been shown to be frequent in patients with septic shock despite "normalization" of systemic hemodynamics. Several studies have explored the impact of vasodilator therapy (prostacyclin, inhaled nitric oxide, topic acetylcholine, and nitroglycerin) on microcirculation and tissue...

Cite
Corrêa TD, Filho RR, Assunção MS, et al. Vasodilators in Septic Shock Resuscitation: A Clinical Perspective. Shock. 2017;47(3):269-275doi: 10.1097/SHK.0000000000000777.
Corrêa, T. D., Filho, R. R., Assunção, M. S., Silva, E., & Lima, A. (2017). Vasodilators in Septic Shock Resuscitation: A Clinical Perspective. Shock (Augusta, Ga.), 47(3), 269-275. https://doi.org/10.1097/SHK.0000000000000777
Corrêa, Thiago Domingos, et al. "Vasodilators in Septic Shock Resuscitation: A Clinical Perspective." Shock (Augusta, Ga.) vol. 47,3 (2017): 269-275. doi: https://doi.org/10.1097/SHK.0000000000000777
Corrêa TD, Filho RR, Assunção MS, Silva E, Lima A. Vasodilators in Septic Shock Resuscitation: A Clinical Perspective. Shock. 2017 Mar;47(3):269-275. doi: 10.1097/SHK.0000000000000777. PMID: 27787407.
Copy Download .nbib Format: NLM
[Clinical experiences and value of vasodilation in myocardial insufficiency].

Verhandlungen der Deutschen Gesellschaft fur Herz- und Kreislaufforschung

Just H.
PMID: 7187166
Verh Dtsch Ges Herz Kreislaufforsch. 1982;48:87-97.

No abstract available.

Cite
Just H. Klinische Erfahrungen und Stellenwert der Gefässdilatation bei Myokardinsuffizienz. [Clinical experiences and value of vasodilation in myocardial insufficiency]. Verh Dtsch Ges Herz Kreislaufforsch. 1982;48:87-97
Just, H. (1982). Klinische Erfahrungen und Stellenwert der Gefässdilatation bei Myokardinsuffizienz. [Clinical experiences and value of vasodilation in myocardial insufficiency]. Verhandlungen der Deutschen Gesellschaft fur Herz- und Kreislaufforschung, 4887-97.
Just, H. "Klinische Erfahrungen und Stellenwert der Gefässdilatation bei Myokardinsuffizienz." [Clinical experiences and value of vasodilation in myocardial insufficiency]. Verhandlungen der Deutschen Gesellschaft fur Herz- und Kreislaufforschung vol. 48 (1982): 87-97.
Just H. Klinische Erfahrungen und Stellenwert der Gefässdilatation bei Myokardinsuffizienz. [Clinical experiences and value of vasodilation in myocardial insufficiency]. Verh Dtsch Ges Herz Kreislaufforsch. 1982;48:87-97. German. PMID: 7187166.
Copy Download .nbib Format: NLM
[Sympathomimetic amines].

Soins; la revue de reference infirmiere

Soupison T.
PMID: 8303405
Soins. 1993 Apr;(571):63-4.

No abstract available.

Cite
Soupison T. Les amines sympathomimétiques. [Sympathomimetic amines]. Soins. 1993;(571):63-4
Soupison, T. (1993). Les amines sympathomimétiques. [Sympathomimetic amines]. Soins; la revue de reference infirmiere, (571), 63-4.
Soupison, T. "Les amines sympathomimétiques." [Sympathomimetic amines]. Soins; la revue de reference infirmiere vol. ,571 (1993): 63-4.
Soupison T. Les amines sympathomimétiques. [Sympathomimetic amines]. Soins. 1993 Apr;(571):63-4. French. PMID: 8303405.
Copy Download .nbib Format: NLM
The importance of the sympathetic nervous system in hypertension. Introduction.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension

van Zwieten PA, Julius S.
PMID: 10489091
J Hypertens Suppl. 1999 Aug;17(3):S1.

No abstract available.

Cite
van Zwieten PA, Julius S. The importance of the sympathetic nervous system in hypertension. Introduction. J Hypertens Suppl. 1999;17(3):S1
van Zwieten, P. A., & Julius, S. (1999). The importance of the sympathetic nervous system in hypertension. Introduction. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 17(3), S1.
van Zwieten, P A, and Julius, S. "The importance of the sympathetic nervous system in hypertension. Introduction." Journal of hypertension. Supplement : official journal of the International Society of Hypertension vol. 17,3 (1999): S1.
van Zwieten PA, Julius S. The importance of the sympathetic nervous system in hypertension. Introduction. J Hypertens Suppl. 1999 Aug;17(3):S1. PMID: 10489091.
Copy Download .nbib Format: NLM
Pathophysiology.

Acta medica Scandinavica. Supplementum

Werkö L.
PMID: 6949467
Acta Med Scand Suppl. 1981;652:9-11. doi: 10.1111/j.0954-6820.1981.tb06781.x.

No abstract available.

Cite
Werkö L. Pathophysiology. Acta Med Scand Suppl. 1981;652:9-11doi: 10.1111/j.0954-6820.1981.tb06781.x.
Werkö, L. (1981). Pathophysiology. Acta medica Scandinavica. Supplementum, 6529-11. https://doi.org/10.1111/j.0954-6820.1981.tb06781.x
Werkö, L. "Pathophysiology." Acta medica Scandinavica. Supplementum vol. 652 (1981): 9-11. doi: https://doi.org/10.1111/j.0954-6820.1981.tb06781.x
Werkö L. Pathophysiology. Acta Med Scand Suppl. 1981;652:9-11. doi: 10.1111/j.0954-6820.1981.tb06781.x. PMID: 6949467.
Copy Download .nbib Format: NLM
Vasopressor support in septic shock.

Chest

Hollenberg SM.
PMID: 17998371
Chest. 2007 Nov;132(5):1678-87. doi: 10.1378/chest.07-0291.

When fluid administration fails to restore an adequate arterial pressure and organ perfusion in patients with septic shock, therapy with vasopressor agents should be initiated. The ultimate goals of such therapy in patients with shock are to restore effective...

Cite
Hollenberg SM. Vasopressor support in septic shock. Chest. 2007;132(5):1678-87doi: 10.1378/chest.07-0291.
Hollenberg, S. M. (2007). Vasopressor support in septic shock. Chest, 132(5), 1678-87. https://doi.org/10.1378/chest.07-0291
Hollenberg, Steven M. "Vasopressor support in septic shock." Chest vol. 132,5 (2007): 1678-87. doi: https://doi.org/10.1378/chest.07-0291
Hollenberg SM. Vasopressor support in septic shock. Chest. 2007 Nov;132(5):1678-87. doi: 10.1378/chest.07-0291. PMID: 17998371.
Copy Download .nbib Format: NLM
Thyroid hormone treatment of congestive heart failure.

The American journal of cardiology

Klein I, Ojamaa K.
PMID: 9485141
Am J Cardiol. 1998 Feb 15;81(4):490-1. doi: 10.1016/s0002-9149(97)00940-5.

No abstract available.

Cite
Klein I, Ojamaa K. Thyroid hormone treatment of congestive heart failure. Am J Cardiol. 1998;81(4):490-1doi: 10.1016/s0002-9149(97)00940-5.
Klein, I., & Ojamaa, K. (1998). Thyroid hormone treatment of congestive heart failure. The American journal of cardiology, 81(4), 490-1. https://doi.org/10.1016/s0002-9149(97)00940-5
Klein, I, and Ojamaa, K. "Thyroid hormone treatment of congestive heart failure." The American journal of cardiology vol. 81,4 (1998): 490-1. doi: https://doi.org/10.1016/s0002-9149(97)00940-5
Klein I, Ojamaa K. Thyroid hormone treatment of congestive heart failure. Am J Cardiol. 1998 Feb 15;81(4):490-1. doi: 10.1016/s0002-9149(97)00940-5. PMID: 9485141.
Copy Download .nbib Format: NLM
Renal Effects of Incretin-Based Diabetes Therapies: Pre-clinical Predictions and Clinical Trial Outcomes.

Current diabetes reports

Thomson SC, Vallon V.
PMID: 29654381
Curr Diab Rep. 2018 Apr 13;18(5):28. doi: 10.1007/s11892-018-0991-7.

PURPOSE OF REVIEW: The purpose of this review is to correlate predictions based on pre-clinical data with outcomes from clinical trials that examine the effects of incretin-based diabetes treatments on the kidney. The incretin-based treatments include agonists of the...

Cite
Thomson SC, Vallon V. Renal Effects of Incretin-Based Diabetes Therapies: Pre-clinical Predictions and Clinical Trial Outcomes. Curr Diab Rep. 2018;18(5):28doi: 10.1007/s11892-018-0991-7.
Thomson, S. C., & Vallon, V. (2018). Renal Effects of Incretin-Based Diabetes Therapies: Pre-clinical Predictions and Clinical Trial Outcomes. Current diabetes reports, 18(5), 28. https://doi.org/10.1007/s11892-018-0991-7
Thomson, Scott C, and Vallon, Volker. "Renal Effects of Incretin-Based Diabetes Therapies: Pre-clinical Predictions and Clinical Trial Outcomes." Current diabetes reports vol. 18,5 (2018): 28. doi: https://doi.org/10.1007/s11892-018-0991-7
Thomson SC, Vallon V. Renal Effects of Incretin-Based Diabetes Therapies: Pre-clinical Predictions and Clinical Trial Outcomes. Curr Diab Rep. 2018 Apr 13;18(5):28. doi: 10.1007/s11892-018-0991-7. PMID: 29654381; PMCID: PMC6426321.
Copy Download .nbib Format: NLM
Peripheral arterial and venous responses to acetylstrophanthidin in patients with acute myocardial infarction.

Clinical pharmacology and therapeutics

Creager MA, Halperin JL, Klein MD, Coffman JD.
PMID: 7140138
Clin Pharmacol Ther. 1982 Dec;32(6):736-43. doi: 10.1038/clpt.1982.230.

The peripheral arterial and venous responses to rapidly active acetylstrophanthidin (rather than the much slower digitalis) were studied in patients with acute myocardial infarction without congestive heart failure. In eight control patients placebo did not change mean blood pressure...

Cite
Creager MA, Halperin JL, Klein MD, et al. Peripheral arterial and venous responses to acetylstrophanthidin in patients with acute myocardial infarction. Clin Pharmacol Ther. 1982;32(6):736-43doi: 10.1038/clpt.1982.230.
Creager, M. A., Halperin, J. L., Klein, M. D., & Coffman, J. D. (1982). Peripheral arterial and venous responses to acetylstrophanthidin in patients with acute myocardial infarction. Clinical pharmacology and therapeutics, 32(6), 736-43. https://doi.org/10.1038/clpt.1982.230
Creager, M A, et al. "Peripheral arterial and venous responses to acetylstrophanthidin in patients with acute myocardial infarction." Clinical pharmacology and therapeutics vol. 32,6 (1982): 736-43. doi: https://doi.org/10.1038/clpt.1982.230
Creager MA, Halperin JL, Klein MD, Coffman JD. Peripheral arterial and venous responses to acetylstrophanthidin in patients with acute myocardial infarction. Clin Pharmacol Ther. 1982 Dec;32(6):736-43. doi: 10.1038/clpt.1982.230. PMID: 7140138.
Copy Download .nbib Format: NLM
Vasopressin and cardiac performance.

Chest

Jackson WL, Shorr AF.
PMID: 12006475
Chest. 2002 May;121(5):1723-4; author reply 1724. doi: 10.1378/chest.121.5.1723-a.

No abstract available.

Cite
Jackson WL, Shorr AF. Vasopressin and cardiac performance. Chest. 2002;121(5):1723-4; author reply 1724doi: 10.1378/chest.121.5.1723-a.
Jackson, W. L., & Shorr, A. F. (2002). Vasopressin and cardiac performance. Chest, 121(5), 1723-4; author reply 1724. https://doi.org/10.1378/chest.121.5.1723-a
Jackson, William L, and Shorr, Andrew F. "Vasopressin and cardiac performance." Chest vol. 121,5 (2002): 1723-4; author reply 1724. doi: https://doi.org/10.1378/chest.121.5.1723-a
Jackson WL, Shorr AF. Vasopressin and cardiac performance. Chest. 2002 May;121(5):1723-4; author reply 1724. doi: 10.1378/chest.121.5.1723-a. PMID: 12006475.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries